Literature DB >> 9485565

Validation of an improved reversed-phase high-performance liquid chromatography assay with reductive electrochemical detection for the determination of artemisinin derivatives in man.

M A van Agtmael1, J J Butter, E J Portier, C J van Boxtel.   

Abstract

For the determination of artemisinin (ART) and analogs, a reversed-phase high-performance liquid chromatography method using reductive electrochemical detection (ED) was set up with some important modifications as compared to previously published assays. A different technique of deoxygenating resulted in a factor 2-3 lower background current. A Spectroflow 400 liquid chromatograph in combination with a Triathlon autoinjector coupled to a Decade electrochemical detector was used. The detector was operated in the reductive mode as a closed system under chromatography grade helium to exclude any access of oxygen. The Decade has a glassy carbon electrode and a reference Ag/AgCl electrode. Infrequent electropolishing was required implicating a very stable system. By increasing acetonitril or lowering the pH of the mobile phase, the various derivatives could be determined in the same chromatogram. The assay was validated using artemether (ATM) and dihydroartemisinin (DHA) as test substances. In the concentration range seen in people after usual doses (5 to 220 ng/ml), the assay performs with adequate accuracy and precision. The interassay and intraassay precision are < 6% for ATM. For DHA, the interassay and intraassay precision are < 9%. The accuracy expressed as the deviation from the expected concentration varies from -1% to +4.5% for the intraassay ATM-determinations and from +1% to +6.3% for the interassay measurements. For DHA, the accuracy is somewhat less, varying from -0.3% to -9.5% for the intraassay measurements and -0.6% to +2.6% for the interassay measurements. The reproducibility of the assay, measured over a time period of 3 months, is good for ATM and DHA with an interassay precision of < 18% in 70 repetitive samples and an accuracy varying from -0.6% to +7.6%. In a cross-check with two other reference laboratories who used comparable methods of determination, a strong correlation (correlation coefficient > 0.98) was achieved. The method was applied in a study in which artemether was administered orally to healthy white subjects. We consider high-performance liquid chromatography with electrochemical detection an accurate and precise method for quantitative determination of artemisinin derivatives in pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485565     DOI: 10.1097/00007691-199802000-00020

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  5 in total

1.  Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.

Authors:  Claire Nealon; Arnaud Dzeing; Ulrich Müller-Römer; Timothy Planche; Veronique Sinou; Maryvonne Kombila; Peter G Kremsner; Daniel Parzy; Sanjeev Krishna
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.

Authors:  N X Khanh; P J de Vries; L D Ha; C J van Boxtel; R Koopmans; P A Kager
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

3.  The contribution of the enzymes CYP2D6 and CYP2C19 in the demethylation of artemether in healthy subjects.

Authors:  M A van Agtmael; C A Van Der Graaf; T K Dien; R P Koopmans; C J van Boxtel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

4.  An ultra-high performance chromatographic method for the determination of artemisinin.

Authors:  Richard A Graves; Grace Ledet; Cedric A Nation; Porscha Renee Showers; Yashoda Pramar; Tarun Mandal; Levon A Bostanian
Journal:  Drug Dev Ind Pharm       Date:  2014-04-16       Impact factor: 3.225

5.  Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum.

Authors:  Paktiya Teja-Isavadharm; James O Peggins; Thomas G Brewer; Nicholas J White; H Kyle Webster; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.